Download - Europe Direct Iasi
Download - Europe Direct Iasi
Download - Europe Direct Iasi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CLASS 4 EUROINVENT 2010 CLASA 4<br />
4.54.<br />
12-Hydroperoxi-8a,12-epoxy-11-bishomodrimane for use in<br />
Title EN<br />
treating mycotic infections<br />
12-Hydroperoxi-8a,12-epoxy-11-bishomodrimane pentru<br />
Titlu RO<br />
tratarea infectiilor micotice<br />
Vlad Pavel, Cicicova Caleria, Arîcu Aculina, Prisacari<br />
Authors Viorel, Dizdari Ana, Rudic Valeriu, Muşet Gheorghe, Savin<br />
Angela, Proca Ludmila, Goncear Veaceslav<br />
Institution Institute of Chemistry of Academy of Sciences of Moldova<br />
Patent no. Pending<br />
The invention relates to the organic compounds of the<br />
terpenic series, in particular to homodrimanes possessing<br />
Description antimycotic activity.Summary of the invention consists in<br />
EN that 12-hydroperoxi-8a,12-epoxy-11-bishomodrimane may<br />
be used in treating mycotic infections. The result of the<br />
invention consists in increasing the antimycotic activity.<br />
4.55.<br />
Title EN Obtaining technologies of sterols from yeast<br />
Titlu RO Tehnologii de obţinere a preparatelor sterolice din drojdii<br />
Authors<br />
Usatîi Agafia, Molodoi Elena, Topală Lilia, Moldoveanu<br />
Institution<br />
Taisia<br />
Institute of Microbiology and Biotechnology of Academy of<br />
Science of Moldova<br />
Patent no. MD 3538, G2; MD 3570,G2<br />
Description<br />
EN<br />
Descriere<br />
RO<br />
The technology is based on the use of Saccharomyces<br />
carlsbergensis CNMN-Y-15 yeast strain, processes targeted<br />
ergosterol synthesis which significantly increases the final<br />
product. Bioproducts "ERGOS-B" and "BILEV" are<br />
proposed to obtain various therapeutic preparations.<br />
Tehnologia se bazează pe utilizarea tulpinii de drojdie<br />
Saccharomyces carlsbergensis CNMN-Y-15, procedeelor de<br />
sinteză orientată a ergosterolului, extragere şi purificare,<br />
care permit sporirea semnificativă a produsului finit.<br />
Bioprodusele „ERGOS-B” şi „BILEV” se propun pentru<br />
obţinerea diferitor preparate terapeutice.<br />
87